Stock ZYDUSLIFE ZYDUS LIFESCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 06:49:34 2025-01-15 am EST 		5-day change 1st Jan Change
984.90 INR -1.52% Intraday chart for Zydus Lifesciences Limited -1.59% +1.36%
Jan. 10 Nomura Upgrades Zydus Lifesciences to Buy From Neutral, Adjusts Price Target to INR1,140 From INR1,030 MT
Jan. 07 CVS Health Unit to Include Zydus Lifesciences' Diabetes Medications in Template Formulary MT

Press Releases

Search
See the results
Zydus announces agreement with CVS Caremark to add ZituvioTM, ZituvimetTM andZituvimetTM XR to its template formulary
Jan. 08
 AQ
Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 Product Candidate for Treatment of Menkes Disease
Jan. 07
 AQ
Zydus receives final approval from USFDA for Scopolamine Transdermal System 1 mg/3 days
24-09-02
 AQ
Zynext Ventures Invests in neuro42, A Company Developing Portable MRI Systems for Neuroimaging and Interventions
24-08-15
 AQ
Zynext Ventures, the VC arm of Zydus Lifesciences, Announces Investment in Promaxo: Pioneering Point-of-Care Medical Imaging and Interventions with Next Generation MRI Systems
24-06-18
 AQ
Sentynl Therapeutics Announces Global Acquisition of Zokinvy for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals
24-05-06
 AQ
Zydus launches Mirabegron Extended-Release Tablets in the US
24-04-22
 BU
PharmaJet Tropis Intradermal Delivery System is Now Authorized for Two Nucleic Acid Vaccines
23-06-29
 AQ
Zydus Lifesciences : Loss of Share Certificates
22-12-28
 PU
Tetanus Pipeline Analysis: 20+ Companies are Working to Improve the Treatment Space | DelveInsight
22-10-18
 AQ
Hepatitis A Pipeline Landscape Analysis of 3+ Companies by DelveInsight
22-10-12
 AQ
Zydus Lifesciences : General updates
22-10-07
 PU
BridgeBio Pharma and Sentynl Therapeutics Receive Marketing Authorization in the EU for NULIBRY for the Treatment of MoCD Type A
22-09-21
 AQ
Zydus Lifesciences : receives final approval from the USFDA for Lenalidomide Capsules 5 mg, 10 mg, 15 mg and 25 mg
22-09-13
 PU
Zydus Lifesciences : receives final approval and 180 days shared exclusivity from the USFDA for Cariprazine Capsules
22-09-12
 PU
Zydus Lifesciences : announces positive Phase 2 Proof-of-Concept of NLRP3 inhibitor, ZYIL1 in patients with Cryopyrin Associated Periodic Syndrome (CAPS)
22-09-07
 PU
Zydus Lifesciences : announces Phase IV DREAM-CKD trial to generate Real World Evidence of Desidustat in patients with Chronic Kidney Disease induced anemia
22-08-30
 PU
Zydus Lifesciences : Transcript of the 27th Annual General Meeting
22-08-27
 PU
Zydus Lifesciences : Loss of share certificate
22-08-24
 PU
Zydus Lifesciences : Q1 FY23 Earnings Call Transcript13 August 2022 Format
22-08-13
 PU
Zydus Lifesciences : receives final approval from the USFDA for Prochlorperazine Maleate Tablets
22-08-12
 PU
BridgeBio Pharma, Sentynl Therapeutics and Medison Pharma Announce Approval in Israel for NULIBRY (fosdenopterin) for the Treatment of MoCD Type A
22-08-11
 AQ
Zydus Lifesciences : Earnings Call Audio Q1 FY23 – August 202210 August 2022 Format
22-08-10
 PU
Zydus Lifesciences : Financial Performance for Q1 FY23
22-08-10
 PU
Zydus Lifesciences : August 2022
22-08-10
 PU
Become a member to access more news.
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZYDUSLIFE Stock
  4. News Zydus Lifesciences Limited
  5. Press Releases